Cipher Pharmaceuticals Reports 2015 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/4/2026
- Dow jumps to record closing high after soft US jobs data, Nasdaq down with chip shares
- Goldman's Garrett sees investors dialing back tech exposure into H2
- AI chip winners may face tougher road ahead as hyperscalers catch up: JPM
- Oil gains on short-covering buys ahead of US holiday
- Rivian stock jumps 5% on raised delivery outlook
Cipher Pharma (CPHR) Tops Q4 EPS by 8c
February 24, 2016 7:54 AM ESTCipher Pharma (NASDAQ: CPHR) reported Q4 EPS of $0.08, $0.08 better than the analyst estimate of $0.00. Revenue for the quarter came in at $9.7 million versus the consensus estimate of $9.31 million.
For earnings history and earnings-related data on Cipher Pharma (CPHR) click here.
... More